Provided by Tiger Fintech (Singapore) Pte. Ltd.

Denali Therapeutics Inc.

11.78
-1.0100-7.90%
Post-market: 11.780.00000.00%19:25 EDT
Volume:1.53M
Turnover:18.05M
Market Cap:1.71B
PE:-4.58
High:12.63
Open:12.32
Low:11.33
Close:12.79
Loading ...
Apr 02, 2025

Major Issues Report

Form 8-K - Current report
Mar 05, 2025

Major Issues Report

Form 8-K - Current report
Feb 27, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 27, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 27, 2025

Major Issues Report

Form 8-K - Current report
Jan 13, 2025

Major Issues Report

Form 8-K - Current report
Jan 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 07, 2025

Major Issues Report

Form 8-K - Current report
Jan 02, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 31, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 18, 2024

Major Issues Report

Form 8-K - Current report
Nov 12, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Nov 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 08, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]